Skip to Main Content

Paper Details

Impaired SARS-CoV-2 Variant Neutralization and CD8+ T-cell Responses Following 3 Doses of mRNA Vaccines in Myeloma: Correlation with Breakthrough Infections.
Blood Cancer Discov
16
2023
+, B, B/T-cell, CD4, CD4+, CD4+ T cells, CD8, CD8+, CD8+ T-cell, MM, Myeloma, Patients, SARS, SARS-CoV, SARS-CoV-2, SARS-CoV-2 mRNA, T cells, VOC nAbs, WA1, class-switched memory B cells, mRNA, multiple myeloma, myeloma, nAb, patients, receptor-binding domain, spike, spike-specific CD8+ T cells, spike-specific T cells
Author NameAffiliation
Craig C HofmeisterEmory University
Craig C HofmeisterWinship Cancer Institute
Sagar LonialEmory University
Sagar LonialWinship Cancer Institute
Alessandro SetteLa Jolla Institute of Immunology
Alessandro SetteLa Jolla Institute of Immunology
Rafi AhmedWinship Cancer Institute
Rafi AhmedEmory University
Rafi AhmedEmory University
Mehul S SutharEmory University
Mehul S SutharEmory National Primate Research Center
Mehul S SutharEmory University
Mehul S SutharEmory University School of Medicine
  • 1 - 13

Datasets

Release 1.2